ENB:NYSEEnbridge Inc Analysis
Data as of 2026-03-31 - not real-time
$54.17
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Enbridge (ENB) is trading in a bullish technical environment, with price above both its short‑term moving averages and a rising volume trend, while the RSI sits in the upper half of the neutral range. The MACD shows a bearish histogram but the overall trend remains bullish, and the stock is approaching a key resistance level. Fundamentally, the company delivers a strong dividend yield and solid operating margins, yet its DCF‑derived fair value is far below the current price, indicating significant overvaluation. Recent analyst upgrades and positive commentary on dividend growth reinforce the income narrative, but the high payout ratio above 100% raises sustainability concerns.
The energy midstream sector presents moderate risk, with low market beta but notable regulatory and geographic exposure in North America. High leverage and a modest free cash flow generation add to the downside pressure, while the dividend’s attractiveness and long‑term contracted pipeline revenues support a more defensive, income‑focused stance for patient investors.
The energy midstream sector presents moderate risk, with low market beta but notable regulatory and geographic exposure in North America. High leverage and a modest free cash flow generation add to the downside pressure, while the dividend’s attractiveness and long‑term contracted pipeline revenues support a more defensive, income‑focused stance for patient investors.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near technical resistance
- Bearish MACD histogram signal
- Overvaluation relative to DCF
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Strong dividend yield and recent analyst upgrades
- Stable operating margins and cash flow generation
- Continued valuation gap and high payout ratio
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Long‑term contracted pipeline revenues
- Defensive income profile in a regulated sector
- Potential for dividend growth despite current payout level
Key Metrics & Analysis
Financial Health
Revenue Growth5.90%
Profit Margin11.49%
P/E Ratio23.5
ROE11.56%
ROA3.38%
Debt/Equity161.40
P/B Ratio3.0
Op. Cash Flow$12.3B
Free Cash Flow$-239250000
Industry P/E23.6
Technical Analysis
TrendBullish
RSI57.6
Support$52.50
Resistance$55.44
MA 20$54.06
MA 50$51.95
MA 200$48.36
MACDBearish
VolumeIncreasing
Fear & Greed Index74.71
Valuation
Fair Value$18.96
Target Price$49.99
Upside/Downside-7.72%
GradeOvervalued
TypeValue
Dividend Yield5.23%
Risk Assessment
Beta0.12
Volatility13.73%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.